Abstract-Aerobic exercise training leads to a physiological, nonpathological left ventricular hypertrophy; however, the underlying biochemical and molecular mechanisms of physiological left ventricular hypertrophy are unknown. The role of microRNAs regulating the classic and the novel cardiac renin-angiotensin (Ang) system was studied in trained rats assigned to 3 groups: (1) sedentary; (2) swimming trained with protocol 1 (T1, moderate-volume training); and (3) protocol 2 (T2, high-volume training). Cardiac Ang I levels, Ang-converting enzyme (ACE) activity, and protein expression, as well as Ang II levels, were lower in T1 and T2; however, Ang II type 1 receptor mRNA levels (69% in T1 and 99% in T2) and protein expression (240% in T1 and 300% in T2) increased after training. Ang II type 2 receptor mRNA levels (220%) and protein expression (332%) were shown to be increased in T2. In addition, T1 and T2 were shown to increase ACE2 activity and protein expression and Ang (1-7) levels in the heart. Exercise increased microRNA-27a and 27b, targeting ACE and decreasing microRNA-143 targeting ACE2 in the heart. Left ventricular hypertrophy induced by aerobic training involves microRNA regulation and an increase in cardiac Ang II type 1 receptor without the participation of Ang II. Parallel to this, an increase in ACE2, Ang (1-7), and Ang II type 2 receptor in the heart by exercise suggests that this nonclassic cardiac renin-angiotensin system counteracts the classic cardiac renin-angiotensin system. These findings are consistent with a model in which exercise may induce left ventricular hypertrophy, at least in part, altering the expression of specific microRNAs targeting renin-angiotensin system genes. Together these effects might provide the additional aerobic capacity required by the exercised heart. (Hypertension. 2011;58:182-189.) • Online Data Supplement Key Words: aerobic exercise training Ⅲ cardiac hypertrophy Ⅲ renin angiotensin system Ⅲ microRNAs Ⅲ angiotensin II receptors Ⅲ ACE2 Ⅲ angiotensin (1-7)
L eft ventricular hypertrophy (LVH) induced by aerobic exercise training is an important physiological compensatory mechanism in response to chronic increases in hemodynamic overload. This phenotype is associated with sarcomeres added in series to lengthen the cardiac cell, as well as in parallel. The increased cross-sectional area contributes to increased ventricular stroke volume and cardiac output, which improves aerobic capacity. In contrast, pathological LVH in cardiovascular diseases is associated with increased fibrosis and lowered aerobic capacity, leading to high mortality. [1] [2] [3] Several studies have reported that the renin-angiotensin (Ang) system (RAS) plays an important role in the progression of LVH. 4 -6 However, there are only limited data about the mechanisms of exercise training involved in RAS and LVH. The aim of this study was to elucidate these mechanisms of exercise training on physiological LVH.
Pathological LVH occurs with arterial hypertension, 7,8 myocardial infarction, 9,10 and heart failure. 11 These disease states are also associated with increased local cardiac RAS levels, represented by augmented angiotensinogen, angiotensin-converting enzyme (ACE), and angiotensin II (Ang II). Blockade of the classic RAS promotes therapeutic benefits to patients with essential hypertension and cardiovascular disease. 8 Cardiac Ang II is implicated in the induction of fibrosis but is not required for LVH. 12 LVH is produced without the participation of Ang II in transgenic animal models for RAS components [13] [14] [15] and in Ang II type 1 (AT 1 ) receptor activation by mechanical stress. 16 -18 A novel cardiac RAS includes ACE2, which is an essential regulator of heart function 19 and plays a pivotal role in Ang (1) (2) (3) (4) (5) (6) (7) formation. This novel RAS is implicated in vasodilatation and control of fibrosis. 20 -23 Previous findings suggest that ACE2 maintains the important balance between the Ang II and Ang (1-7), favoring cardiovascular homeostasis. However, the role of exercise training in the cardiac ACE2-Ang (1-7) axis is unknown. We have shown that AT 1 receptor blockade prevents physiological LVH induced by resistance training 18 and by aerobic exercise training. 24 Moreover, exercise training promoted LVH by cardiac RAS stimulation independent of the systemic RAS. 18, 24 Several genes are regulated by microRNAs (miRNAs). MiRNAs are endogenous, small, and noncoding RNAs, which are targeted to specific genes and function as negative regulators of gene expression by inhibiting translation or promoting degradation of target mRNAs. Recent studies have shown the roles played by miRNAs in different forms of cardiovascular disease and pathological LVH. 25, 26 However, miRNAs may be important for normal development and in physiological cardiac hypertrophy induced by aerobic exercise training. In the present study, it was hypothesized that exercise training alters specific miRNAs that regulate their target cardiac RAS genes and tip the balance of classic RAS genes in favor of the novel RAS genes to contribute to physiological LVH.
Materials and Methods

Animal Care
All of the protocols and surgical procedures used were in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the ethics committee of the University of Sao Paulo School of Physical Education and Sport. Female normotensive Wistar rats (190 to 220 g, nϭ42) were used. The animals were housed 3 to 5 per cage at a controlled room temperature (22°C) with a 12-hour dark-light cycle and fed standard rat chow, having access to water ad libitum.
The rats were randomly divided into 3 experimental groups, each with 14 rats: (1) sedentary (S; nϭ7); (2) swimming trained with protocol 1 (T1; nϭ7); and (3) swimming trained with protocol 2 (T2; nϭ7). Each group was subdivided into 2 groups, one for hemodynamic, biochemical, and molecular studies and the other for morphological and histological studies. For the detailed Material and Methods section, please see the online Data Supplement, available at http://hyper.ahajournals.org. Table 1 summarizes systolic blood pressure, diastolic blood pressure, mean blood pressure, and heart rate results of the groups S, T1, and T2. There were no differences in blood pressure among the 3 groups. However, heart rate decreased significantly after 10 weeks of swimming training in the T1 (301.2Ϯ15.3 bpm) and T2 (309Ϯ14 bpm) groups when compared with the S group (344.8Ϯ12.1 bpm; PϽ0.05).
Results
Hemodynamic Parameters
Cardiac Hypertrophy
Body weight (BW) before and after swimming training was similar among all of the studied groups. Left ventricle (LV) and right ventricle (RV)/BW ratios were used as indices of hypertrophy. The absolute values referring to BW, LV/BW, and RV/BW in all of the groups of rats are summarized in the Table 2 . LVH obtained by T1 and T2 was 13% (2.8Ϯ0.14 mg/g; PϽ0.05) and 27% (3.2Ϯ0.12 mg/g; PϽ0.01), respectively, in comparison with the S group (2.5Ϯ0.06 mg/g). RV hypertrophy obtained by T1 and T2 was 15% (0.68Ϯ0.06 mg/g; PϽ0.05) and 35% (0.80Ϯ0.08 mg/g; PϽ0.01), respectively, in comparison with the S group (0.59Ϯ0.04 mg/g). The increase in LV/BW ratio observed with swimming training was further confirmed by the increase in LV myocyte diameter in T1 (13.2Ϯ1.3 m) and T2 (14.4Ϯ1.3 m) groups when compared with the S group (11.0Ϯ1.1 m; PϽ0.05; Table 2 ). Figure S1 , available in the online Data Supplement at http://hyper.ahajournals.org, shows representative histological sections of increase in LV myocyte diameter in T1 and T2 in comparison with the S group.
Molecular Markers of Pathological LVH
Pathological cardiac hypertrophy is characterized by the induction of genes normally expressed during fetal development, such as atrial natriuretic factor, skeletal muscle ␣-actin, and a decrease in the ratio of ␣/␤-myosin heavy chain. The mRNA levels of these 4 genes were assessed in the LV of S and trained groups (T1 and T2) by real-time PCR. The results of this study showed that swimming training did not modify atrial natriuretic factor gene expression. Similarly, T1 training did not change the gene levels of skeletal ␣-actin and ␣/␤-myosin heavy chain, although T2 exercise significantly reduced the LV levels of skeletal ␣-actin by 53% (PϽ0.05) and increased the LV levels of ␣/␤-myosin heavy chain by 98% (PϽ0.05), when compared with the S group.
RAS Biochemical Analysis
To evaluate the role of swimming exercise training in systemic RAS, the serum ACE activity and plasma renin activity were measured. Figure 1A shows that there was an increase in serum ACE activity of 3.8% in T1 (P value not significant [NS]) and 23.5% in T2 (PϽ0.05) in comparison with the S group. Plasma renin activity also was increased by 20% in T1 (PϭNS) and 126% in T2 (PϽ0.01) when compared with the S group ( Figure 1A ). In contrast, there was a reduction in local cardiac ACE activity of 11% (PϭNS) and 15% (PϭNS) in the RV and LV, respectively, in the T1 group. When the T2 group was compared with the S group, there was a decrease of 40% (PϽ0.05) and 32% (PϽ0.05) in RV and LV, respectively ( Figure 1B) . Interestingly, Figure  1B 
RAS Molecular Analysis
In order to test whether swimming exercise training modulates cardiac RAS gene expression, real-time PCR was used to assess ACE, ACE2, AT 1 , and Ang II type 2 (AT 2 ) receptor gene expression in the heart. mRNA levels of ACE showed a small decrease and ACE2 mRNA a small increase in both trained groups but without significance (data not shown). AT 1 receptor gene expression increased in T1 (69%; PϽ0.05) and T2 (99%; PϽ0.01) when compared with the S group ( Figure  4B ). In addition, AT 2 receptor gene expression increased by 26% (PϭNS) in T1 and 332% in T2 (PϽ0.001); T1 differed from T2 (PϽ0.001; Figure 4D ). Similar results were obtained for RAS proteins and peptide levels determined by Western blotting and high-performance liquid chromatography, respectively. Figure 2A shows that swimming exercise training decreased cardiac angiotensinogen levels by 26% (PϽ0.05) in T1 and 44% in T2 (PϽ0.05) when compared with the S group. Because angiotensinogen is a substrate for Ang I production, this reduction was accompanied by a decrease of 25.6% (PϽ0.05) in cardiac Ang I levels in T1 and 44% in T2 (PϽ0.001) when compared with the S group ( Figure 2B ). The next step was to measure the levels of ACE, because it is responsible for converting Ang I into Ang II. Accordingly, Figure 2C shows that cardiac ACE levels were decreased by 22% (PϭNS) in T1 and 31% in T2 (PϽ0.05) in comparison with the S group. This reduction was accompanied by a decrease of 23% (PϽ0.001) in Ang II levels in T1 and 20% in T2 (PϽ0.001) in comparison with the S group ( Figure 2D ), indicating an attenuation of the ACEAng II axis induced by swimming exercise training.
Swimming exercise training also had an effect on the protein and peptide levels of novel RAS, ACE2, and Ang (1-7) in the heart. As shown in Figure 3A , swimming training increased ACE2 protein expression in both trained groups (68% in T1 and 91% in T2; PϽ0.05) when compared with the S group. There was increased Ang (1-7) formation (160% in T1 and 120% in T2; PϽ0.01; Figure 3B ) in comparison with the S group. Figure 3C shows an increase in the Ang (1-7)/Ang II ratio in both trained groups (180% in T1, PϽ0.05, and 160% T2, PϽ0.001) in comparison with the S group, suggesting an aerobic training-mediated increase in Ang (1-7) formation from Ang II by ACE2.
Protein expression of the AT 1 receptor, in concert with the increase in AT 1 receptor mRNA levels, was 2.4-fold greater in T1 (PϽ0.05) and 3.0-fold greater in T2 (PϽ0.05) when compared with the S group ( Figure 4A ). In addition, AT 2 receptor protein expression was increased 1.6-fold in T1 (PϭNS) and 2.2-fold (PϽ0.05) in T2 ( Figure 4C ).
MiRNAs Analysis by Microarray
Microarray analysis of miRNA was restricted to those miRNAs that underwent a significant change from baseline. Figure 5A shows miRNAs targeting ACE: in the S group the relative expression value of miRNA-27a was 1760Ϯ108 arbitrary units (AU). In the T1 group the value was 2225Ϯ78 AU, (26% increase in comparison with S; PϽ0.05), and in T2 group the expression was 3218Ϯ30 AU (83% increase in comparison with S; PϽ0.01). In addition, T1 differed from T2 (PϽ0.01). Similarly, in the S group the relative expression value of miRNA-27b was 3409Ϯ89 AU. In the T1 group the value was 4341Ϯ124 AU, (27% increase in comparison with S; PϽ0.05), and in the T2 group the expression was 4939Ϯ59 AU (45% increase in comparison with S; PϽ0.01). In addition, T1 differed from T2 (PϽ0.01). Figure 5A also shows miRNA targeting ACE2: in the S group the relative expression value of miRNA-143 was 6556Ϯ157 AU; T1ϭ6095Ϯ83 AU was not significant when compared with S; however, in the T2 group the expression was 4249Ϯ32 AU 
MiRNAs Analysis by Real-Time PCR
To confirm the miRNAs that targeted RAS genes in physiological LVH, the miRNAs 27a, 27b, and 143 were quantified by real-time PCR. MiRNAs 27a (S: 1.0Ϯ0.08, T1: 1.52Ϯ0.06, and T2: 2.04Ϯ0.13 AU) and 27b (S: 1.0Ϯ0.08, T1: 1.30Ϯ0.05, and T2: 1.59Ϯ0.08 AU) were upregulated in T1 and T2 in comparison with S, whereas miRNA-143 (S:
1.0Ϯ0.11, T1: 0.82Ϯ0.02, T2: 0.58Ϯ0.05 AU) was downregulated in T2 in comparison with S. The miRNA expression in T1 and T2 in comparison with the S group confirmed the microarray results.
Discussion
The results of the present study show that swimming exercise training induced physiological LVH, is not correlated with pathological cardiac hypertrophy markers, increased AT 1 and AT 2 receptor expression, decreased cardiac ACE and Ang II A   T1  T2  S  T1  T2  S   ACE  α-tubulin   T1  T2  S  T1  T2  S   Angiotensinogen  α-tubulin   0   *   T1  T2  S  T1  T2  S  T1  T2  S  T1  T2  S  T1  T2  S  T1  T2  S  T1  T2  S  T1  T2 The LV/ BW ratio, myocyte diameter, and resting bradycardia confirmed the exercise-associated adaptations of physiological LVH. 24, 27 In contrast to markers for pathological hypertrophy, 28 the physiological LVH reported here was not associated with activation of fetal genes, such as atrial natriuretic factor, skeletal muscle ␣-actin, and ␤-myosin heavy chain. There were no pathological hypertrophy markers in the exercised-trained T1 or T2 groups.
The development of LVH after training did not appear to involve Ang II, which was decreased, supporting recent evidence from several transgenic animal models that increased formation of local Ang II in the heart does not directly develop hypertrophy, except when excess cardiac Ang II enters the circulation and causes an increase in blood pressure. [12] [13] [14] Xiao et al 15 reported that, in mice expressing ACE only in the heart, increased cardiac Ang II was not associated with cardiac hypertrophy. Our group demonstrated that, in transgenic mice harboring 1, 2, 3, or 4 ACE gene copies, the magnitude of physiological LVH induced by swimming training was not correlated with ACE levels. 17 Increased AT 1 receptor was also found with resistance training. 18 Losartan treatment blocked LVH in the same 2 swimming training protocols. 24 The mechanism for overexpressing the AT 1 receptor may be related to an independent action of the AT 1 receptor. Zou et al 16 showed in vitro and in vivo that AT 1 receptor is a mechanical sensor and converts mechanical stress into a biochemical signal inducing LVH without involvement of Ang II. Moreover, Yasuda et al 29 showed that mechanical stress activates an anticlockwise rotation of the transmembrane 7 domain of AT 1 receptor, causing a conformational change of the receptor, independent of Ang II. AT 1 receptors have no direct cell signaling pathway to tyrosine kinase and the mitogen-activated protein kinase pathways for cell growth. 30, 31 The AT 1 receptors have an indirect, membrane-transactivating step to stimulate the epidermal growth factor receptor. 30, 31 Inhibition of the epidermal growth factor receptor directly prevents Ang IIinduced LVH in rats. 31 The mechanical activity of exercise could, therefore, activate the epidermal growth factor receptor pathway via mechanical activation of AT 1 , even in the absence of Ang II.
Aerobic exercise training also increased AT 2 receptor genes and protein expression in the LV. Studies suggest that AT 1 and AT 2 receptors may serve opposing functions in the heart, although they exhibit the same ligand binding affinity. 4, 12 The role of AT 2 receptors in cardiac regulation is not fully understood. The AT 2 receptor has been associated with dephosphorylation and inactivation of growth factor-activated mitogen-activated protein kinase and inactivation of extracellular signal-regulated kinase 1/2, providing a protective role in the heart. 32 Furthermore, AT 2 receptor activates NO and bradykinin, inducing vasodilation. 33 Yang et al 34 demonstrated that, in transgenic animals, the overexpression of AT 2 receptors preserved LV function after myocardial infarction. The results of the present study suggest that the AT 2 receptor plays a cardioprotective role in opposing deleterious cardiac remodeling in cardiovascular disease. In contrast to the pathological condition, an increase in AT 2 receptor expression in the heart could aid vasodilatation induced by aerobic exercise training. This modulation might increase blood and oxygen transport to the exercising cardiac muscle to facilitate high performance. The present study demonstrated the effect of aerobic exercise training on ACE2 and Ang (1-7) in the heart of rats. The discovery of ACE2 revealed that classic RAS has a reciprocal side, the novel RAS. The results of this study show a reversal of balance in favor of the novel RAS with exercise training. When compared with sedentary animals, the trained groups had increased ACE2 and Ang (1-7) activity and protein expression in the LV. ACE2 cleaves Ang I to generate the inactive Ang (1-9) peptide, but the preferred pathway with 500-fold greater efficiency is Ang II to generate the vasodilator Ang (1-7) . 6, 35, 36 In hypertension, a decrease in ACE2 mRNA and protein expression, leads to increases in local Ang II levels and might reduce myocardial blood flow, preferentially via coronary vasoconstriction or microcirculatory dysfunction. However, with the use of ACE inhibitor or AT 1 receptor blocker, the ACE2 level is enhanced. [35] [36] [37] Transgenic animal models overexpressing cardiac ACE2 by systemic lentiviral delivery resulted in a regression of pathological LVH in hypertensive rats. 21 In fact, studies have suggested that Ang (1-7) can reduce hypertension-induced cardiac remodeling through a direct effect on the heart and raise the possibility that pathologies associated with ACE2 inactivation are partly mediated by a decrease in Ang (1-7) production. 38, 39 AT 1 receptor blockade augmented the plasma Ang (1-7)/ Ang II ratio, suggesting increased generation of Ang (1-7) from Ang II. 20 In addition, Crackower et al 19 showed that deletion of ACE2 in mice resulted in elevated cardiac and plasma Ang II, together with impaired cardiac contractility and exhibited LV dilatation. Therefore, ACE2 might protect against pathological LVH by reducing Ang II concentration and increasing Ang (1-7) generation. 6,20 -23,38,39 Thus, the mechanism of aerobic exercise training to prevent LVH could occur by diminished vascular resistance, leading to increased cardiac flow, attributed to the reduction in ACE and Ang II levels and the vasodilator effects of the ACE2-Ang (1-7) expression, mediating the release of different vasoactive factors, such as NO, prostaglandins, and bradykinin. 40, 41 Another aspect of this report is the correlation of miRNAs with Ang-related genes. The implication of specific miRNAregulating RAS genes in cardiac hypertrophy induced by exercise training has not been reported previously. The target predictions of miRNAs are all based on 3Јuntranslated regions of mRNA of RAS components in Web-based bioinformatics TargetScan 4.2 and 5.1, MiRanda, and PicTar. Confirming these predictions, the literature provides more details of Ang gene regulation through quantitative PCR and Ang gene measurements. The ACE gene has been shown recently to be regulated by miRNA-27a and 27b. 42 It has been demonstrated that the ACE2 gene is regulated by miRNA-143. 43 This study reveals potential molecular mechanisms for the results. MiRNAs target multiple genes, but targeted genes are controlled by specific miRNAs. 25, 26 Increased expression of miRNA indicates inhibition of the target gene. This appears to be the case with miRNA-27a and -27b, because ACE decreased by 22% (T1) and 31% (T2) in comparison with the control, whereas miRNA-27a increased by 26% (T1) and 88% (T2) when compared with the control, and miRNA-27b increased by 27% (T1) and 44% (T2). By the same principle, decreased expression of miRNAs reflects increased expression of target genes. Although, in the T2 group in which the expression of ACE2 was highest, the miRNAs that target the ACE2 gene, miRNA-143, were at their lowest level of expression when compared with the control or T1. Thus, aerobic exercise training exerts an effect on the expression of miRNAs and thereby might regulate their specific target genes.
Perspectives
Exercise is widely recognized as an important lifestyle factor in lowering hypertension and improving cardiac health. This study reveals some of the biochemical and molecular mechanisms of aerobic exercise training involved in physiological, nonpathological cardiac hypertrophy. The results clearly indicate that, in aerobic exercise trained animals, LVH is physiological and associated with decreased ACE and Ang II versus increased ACE2 and Ang (1-7) and increased AT 1 and AT 2 receptors. In addition, there was a reciprocal differential expression of specific miRNAs and these genes. These findings are consistent with a model in which exercise may influence these changes, at least in part, altering the expres- 
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sion of specific miRNAs targeting RAS genes. Together, these effects might provide the additional aerobic capacity required by the exercised heart. The results imply that a decrease in miRNA-143 could upregulate cardioprotective genes in the heart, and an increase of miRNA-27 expression inhibits ACE levels. These results suggests that a basis for treatment to prevent of the development of pathological LVH might be to inhibit specific miRNAs, probably with antisense or small interfering RNA, to inhibit ACE and Ang II and increase ACE2 and Ang (1-7).
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DETAILED METHODS
Exercise Training Protocols
Protocol 1 (T1) low intensity, moderate volume exercise: training consisted of swimming sessions of 60-minute duration, 5 days a week, for 10 weeks, which were carried out between 11:30 AM and 1:30 PM. Protocol 2 (T2) low intensity, high volume exercise: Animals assigned to T2 performed the same swimming training protocol as T1 until the end of the 8 th week. On the 9 th week rats trained twice a day, swimming sessions of sixtyminute duration with four hours interval between sessions. In that week swimming sessions were carried on from 07: 30 It was showed in our previous study that this swimming-training protocol did not stress the animals as it did not alter plasma catecholamine concentration (2) . Exercise duration and workload were increased gradually until rats could swim for 60 minutes wearing caudal dumbbells weighing 5% of their body weight. Thereafter, duration and dumbbells were kept constant. All animals were weighed once a week and the workload adjusted to body weight variations. Sedentary groups were placed in the swimming apparatus for 10 minutes twice a week without workload to control for being in the water. O 2 uptake of rats swimming individually is about 50-65% of maximum oxygen uptake. This low intensity long period training protocol is effective for promotion of cardiovascular adaptations and for increase of muscle oxidative capacity. These protocols have already been used previously in our laboratory (1,2).
Hemodynamic Parameters: Blood Pressure (BP) and Heart Rate (HR)
Twenty-four hours after the last training session BP and HR were recorded. Rats were anesthetized (Ketamine 90 mg.kg -1 and Xylazine 10 mg.kg -1 , i.p.) and a cannula (PE-50) was inserted into the carotid artery and emerged through the back of the neck. Twenty-four hours after the cannula was implanted, this cannula was connected to a strain-gauge transducer (P23 Db; Gould-Statham). Arterial blood pressure was recorded on a beat to beat basis (AT/CODAS) at a frequency of 1000Hz for 30 min in quiet, conscious, unrestrained rats. Recorded data indicated the average of all values of systolic, diastolic, heart rate and mean arterial pressure over the entire recording time of 30 min.
Samples preparation
At the end of the experimental period the rats were decapitated and blood and tissue samples (heart) were harvested, weighed, frozen, stored at -80 o C and used within 1 month for enzymes assay, miRNA, mRNA and protein preparation. To determine plasma angiotensin II the first 3 ml of trunk blood (a mixture of venous and arterial blood) was rapidly collected in chilled glass tubes containing a mixture of potassium EDTA (25 mmol), o-phenanthroline (0.44 mmol), pepstatin A (0.12 mmol), and 4-chloromercuribenzoic acid (1 mmol). This mixture of protease inhibitors prevented the in vitro production and degradation of angiotensin peptides (3) . To determine the renin activity the blood was collected with EDTA (25 mmol). The blood was centrifuged the plasma was separated and stored at -20 o C.
Measurement of Cardiac Hypertrophy
To measure cardiac mass, the hearts were stopped at diastole by perfusion of 14 mM KCl. After the heart was weighed, the left ventricle (LV) was dissected corresponding to the remaining tissue upon removal of both atria and the free wall of the right ventricle (RV). The interventricular septum remained as part of the LV. Cardiac hypertrophy was assessed by the measurement of the ratio of LV and RV weight in milligrams to animal body weight (BW) in grams (LV/BW and RV/BW in mg.g -1 ). The LV was fixed in 6% formaldehyde and embedded in paraffin, cut in 5 μm sections, from the level of papillary muscle and subsequently stained with hematoxylin and eosin (HE) for the visualization of cellular structures. Two randomly selected sections from each animal were visualized by light microscopy using an oil immersion objective with a calibrated magnification (x400). Myocytes with visible nucleus and intact cellular membranes were chosen for diameter determination. The width of individually isolated cardiomyocytes were displayed on a viewing screen that was manually traced, across the middle of the nuclei, with a digitizing pad and determined by a computer assisted image analysis system (Quantimet 520; Cambridge Instruments). For each animal, approximately 20 visual fields were analyzed.
RAS Biochemical Analysis Cardiac and Serum angiotensin-converting enzyme (ACE) activity:
ACE activity was determined in heart tissue and serum using Abz-FRK(Dnp)P-OH derivatives as substrates by continuously measuring the fluorescence according to Alves et al. (4) . Heart samples were quickly harvested, homogenized in 0.1 M Tris-HCl buffer, pH 7.0, containing 50 mM NaCl and centrifuged at 1000 g for 10 min. The assays were performed at 37ºC in 0.1 M Tris-HCl buffer, pH 7.0, containing 50 mM NaCl and 10 µM ZnCl 2 . The hydrolysis rate of the intramolecularly quenched fluorogenic substrate Abz-FRK-(Dnp)P-OH (10 uM) incubated with aliquots of heart homogenate and serum for 30 min at 37ºC was assessed to obtain ACE enzymatic activity. Fluorescence increments along the time were read at 420nm emission: 320nm excitation. Heart and serum ACE activity were expressed as UF.min -1 .mg -1 of protein x 1000. The protein content was determined by the Bradford methods (5) by using bovine serum albumin as the standard (Bio-Rad Protein Assay).
Cardiac angiotensin-converting enzyme 2 (ACE2) activity:
ACE2 activity was determined in heart tissue by the same method described above. However, this method uses a fluorescent peptide Abz-APK(Dnp)-OH in 0.2 M Tris-HCl buffer, 200 mM NaCl, 2 µg BSA, pH 7.5 which is hydrolyzed with high affinity by ACE2 (Kcat/Km = 3,5 x 10 4 M -1 .s -1 ). ACE2 activity was expressed in UF.min -1 .mg -1 of protein.
Plasma renin activity assay:
Plasma renin activity (PRA) was determined by angiotensin radioimmunoassay, using a commercial kit (REN-CT2, CIS Bio International, Gif-sur-Yvette, France). This
